The Latin America, Middle East and Africa Hearing Care Devices Market is expected to witness market growth of 6.7% CAGR during the forecast period (2022-2028).
People's hearing faculties are being negatively impacted by increasing noise pollution around the world. Adults' hearing capacity is projected to be harmed as an outcome of noise pollution in heavy-duty businesses & public carnivals, leading to an increase in the demand for hearing aids. Further, market players in this sector are improving their products through technical innovation and the introduction of new gadgets, which is likely to boost the hearing aids market growth during the forecast period. For example, GN Hearing developed ReSound ONE in 2020, which addresses one of the most persistent problems faced by people with hearing loss. This approach uses a microphone & amp; receiver-in-ear design (M&RIE) to install an additional microphone within the ear canal, which collects sound using the unique shape of each individual's ear.
Moreover, technological improvements bringing to new product launches, changes favouring OTC hearing aid sales, along with favourable reimbursement policies are projected to stimulate demand for hearing aid systems. Government-funded initiatives are also boosting the market for hearing aid support products. The majority of countries with higher penetration rates have government-funded programs, or at the very least, subsidies or full or partial reimbursements for hearing aids & accessories.
Hearing impairment is one of the most disabling congenital disorders, meaning it is present from birth. Congenital hearing loss affects 1-2 per 1,000 new-borns worldwide, although it affects up to 6 per 1,000 in Sub-Saharan Africa. It is advised that children with Hearing Impairments have early diagnosis and care to maximize their cognitive, social-emotional, speech, and language development. EHDI services are scarce in Africa, and in the absence of new-born screening, the age at diagnosis is sometimes relatively late.
About half of all patients born in LAMEA with hearing impairment have NSHI caused by mutation in their DNA. People in the same family, regardless of gender, are frequently impacted by hearing impairment when there is an error that produces a change in the genes. The person diagnosed with hearing impairment, on the other hand, may be the first and only member of their family to be affected. In most cases in LAMEA, neither parent has a hearing problem, but each possess a gene with flaw that could be handed down to their offspring. This type of heredity is known as autosomal recessive (AR), and it accounts for a substantial number of NHSI cases. At birth or within the first several years of life, every child who inherits these two genes with errors from both parents with genetic errors suffer from hearing loss & can pass it on to their offspring. It is possible that more than a thousand NSHI genes have yet to be discovered. Because cultures that have been understudied, such as Sub-Saharan Africans (SSA), may generate genes that play a key role in NSHI, these undiscovered genes are not necessarily infrequent sources of NSHI.
The Brazil market dominated the LAMEA Hearing Care Devices Market by Country 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $216.5 million by 2028. The Argentina market is poised to grow at a CAGR of 7.3% during (2022-2028). Additionally, The UAE market is expected to witness a CAGR of 6.4% during (2022-2028).
Based on Product, the market is segmented into Hearing Aids and Hearing Implants. Based on End User, the market is segmented into Home-use, Ambulatory Surgical Centers (ASCs), and Hospitals & Clinics. Based on Type of hearing loss, the market is segmented into Conductive Hearing Loss and Sensorineural Hearing Loss. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include WS Audiology, Cochlear Ltd., Intricon Corporation, Starkey laboratories, Inc., & nbsp;GN Store Nord A/S (GN Hearing A/S), Sonova Holding AG, William Demant Holding A/S, Amplifon SpA (Ampliter N.V.), and MED-EL GmbH.
By Product
By Country
People's hearing faculties are being negatively impacted by increasing noise pollution around the world. Adults' hearing capacity is projected to be harmed as an outcome of noise pollution in heavy-duty businesses & public carnivals, leading to an increase in the demand for hearing aids. Further, market players in this sector are improving their products through technical innovation and the introduction of new gadgets, which is likely to boost the hearing aids market growth during the forecast period. For example, GN Hearing developed ReSound ONE in 2020, which addresses one of the most persistent problems faced by people with hearing loss. This approach uses a microphone & amp; receiver-in-ear design (M&RIE) to install an additional microphone within the ear canal, which collects sound using the unique shape of each individual's ear.
Moreover, technological improvements bringing to new product launches, changes favouring OTC hearing aid sales, along with favourable reimbursement policies are projected to stimulate demand for hearing aid systems. Government-funded initiatives are also boosting the market for hearing aid support products. The majority of countries with higher penetration rates have government-funded programs, or at the very least, subsidies or full or partial reimbursements for hearing aids & accessories.
Hearing impairment is one of the most disabling congenital disorders, meaning it is present from birth. Congenital hearing loss affects 1-2 per 1,000 new-borns worldwide, although it affects up to 6 per 1,000 in Sub-Saharan Africa. It is advised that children with Hearing Impairments have early diagnosis and care to maximize their cognitive, social-emotional, speech, and language development. EHDI services are scarce in Africa, and in the absence of new-born screening, the age at diagnosis is sometimes relatively late.
About half of all patients born in LAMEA with hearing impairment have NSHI caused by mutation in their DNA. People in the same family, regardless of gender, are frequently impacted by hearing impairment when there is an error that produces a change in the genes. The person diagnosed with hearing impairment, on the other hand, may be the first and only member of their family to be affected. In most cases in LAMEA, neither parent has a hearing problem, but each possess a gene with flaw that could be handed down to their offspring. This type of heredity is known as autosomal recessive (AR), and it accounts for a substantial number of NHSI cases. At birth or within the first several years of life, every child who inherits these two genes with errors from both parents with genetic errors suffer from hearing loss & can pass it on to their offspring. It is possible that more than a thousand NSHI genes have yet to be discovered. Because cultures that have been understudied, such as Sub-Saharan Africans (SSA), may generate genes that play a key role in NSHI, these undiscovered genes are not necessarily infrequent sources of NSHI.
The Brazil market dominated the LAMEA Hearing Care Devices Market by Country 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $216.5 million by 2028. The Argentina market is poised to grow at a CAGR of 7.3% during (2022-2028). Additionally, The UAE market is expected to witness a CAGR of 6.4% during (2022-2028).
Based on Product, the market is segmented into Hearing Aids and Hearing Implants. Based on End User, the market is segmented into Home-use, Ambulatory Surgical Centers (ASCs), and Hospitals & Clinics. Based on Type of hearing loss, the market is segmented into Conductive Hearing Loss and Sensorineural Hearing Loss. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include WS Audiology, Cochlear Ltd., Intricon Corporation, Starkey laboratories, Inc., & nbsp;GN Store Nord A/S (GN Hearing A/S), Sonova Holding AG, William Demant Holding A/S, Amplifon SpA (Ampliter N.V.), and MED-EL GmbH.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Hearing Aids
- Hearing Implants
- Home-use
- Ambulatory Surgical Centers (ASCs)
- Hospitals & Clinics
- Conductive Hearing Loss
- Sensorineural Hearing Loss
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- WS Audiology
- Cochlear Ltd.
- Intricon Corporation
- Starkey laboratories, Inc.
- GN Store Nord A/S (GN Hearing A/S)
- Sonova Holding AG
- William Demant Holding A/S
- Amplifon SpA (Ampliter N.V.)
- MED-EL GmbH
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. LAMEA Hearing Care Devices Market by Product
Chapter 5. LAMEA Hearing Care Devices Market by End User
Chapter 6. LAMEA Hearing Care Devices Market by Type of hearing loss
Chapter 7. LAMEA Hearing Care Devices Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- WS Audiology
- Cochlear Ltd.
- Intricon Corporation
- Starkey laboratories, Inc.
- GN Store Nord A/S (GN Hearing A/S)
- Sonova Holding AG
- William Demant Holding A/S
- Amplifon SpA (Ampliter N.V.)
- MED-EL GmbH
Methodology
LOADING...
